SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-23-003362
Filing Date
2023-10-23
Accepted
2023-10-23 06:43:18
Documents
1
Period of Report
2023-10-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5223
  Complete submission text file 0001178913-23-003362.txt   7087
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 34 YERUSHALAYIM RD. RAANANA L3 4350110
Business Address 34 YERUSHALAYIM RD. RAANANA L3 4350110 972(73)3989560
aMoon Growth Fund Limited Partnership (Reporting) CIK: 0001744099 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36138 | Film No.: 231338476